Skip to content

The effect of acupressure on intramuscular injection pain severity

The effect of acupressure(UB32) on pain severity of intramuscular magnesium sulfate injection(Z technique)in postpartum cesarean section women with severe Precambrian and eclampsia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201410278505N12
Enrollment
47
Registered
2017-01-18
Start date
2016-12-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eclampsia and severe preeclampsia. oedema,proteinurea and hypertensive disorder in pregnancy

Interventions

Intervention 1: The first intervention is intramuscular magnesium sulfate injection with Z technique as a conventional method.5cc of drug will be injected in one buttock and the remaining 5cc will be
Treatment - Drugs
The first intervention is intramuscular magnesium sulfate injection with Z technique as a conventional method.5cc of drug will be injected in one buttock and the remaining 5cc will be injected to the
The second intervention is intramuscular magnesium sulfate injection with Z technique with acupressure in sham control point which is same in all patients and located in 5cm of posterior superior illi
The third intervention is intramuscular magnesuim sulfate injection with Z technique with acupressure in UB32 point.Acupressure point is pressed by thumb directly and continuously with pressure equal

Sponsors

Vice Chancellor for research of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Range of age between 15-45;Willingness to participate;Gynecologist order for magnesium sulfate injection;No chronic pain in lambosacral area including disk herniation Exclusion criteria:Unwillingness to participate ; Any psychological disease including depression ;Allergy to magnesium sulfate; Receiving pain killers befor injection(Except diclofenac suppository);Femur and hip fracture in the last year

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: immediately after injection. Method of measurement: Visual analoge scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSetare Nazaribin

Shiraz University of Medical Sciences

setare1991_2013@yahoo.com+98 71 3825 2704

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026